Motor Sequence Learning across Multiple Sessions Is Not Facilitated by Targeting Consolidation with Posttraining tDCS in Patients with Progressive Multiple Sclerosis.
Harald Seelmann-EggebertMuriel StoppeFlorian Then BerghJoseph ClaßenJost-Julian RumpfPublished in: Neural plasticity (2021)
Compared to relapsing-remitting multiple sclerosis (MS), progressive MS is characterized by a lack of spontaneous recovery and a poor response to pharmaceutical immunomodulatory treatment. These patients may, therefore, particularly benefit from interventions that augment training-induced plasticity of the central nervous system. In this cross-sectional double-blind cross-over pilot study, effects of transcranial direct current stimulation (tDCS) on motor sequence learning were examined across four sessions on days 1, 3, 5, and 8 in 16 patients with progressive MS. Active or sham anodal tDCS of the primary motor cortex was applied immediately after each training session. Participants took part in two experiments separated by at least four weeks, which differed with respect to the type of posttraining tDCS (active or sham). While task performance across blocks of training and across sessions improved significantly in both the active and sham tDCS experiment, neither online nor offline motor learning was modulated by the type of tDCS. Accordingly, the primary endpoint (task performance on day 8) did not differ between stimulation conditions. In sum, patients with progressive MS are able to improve performance in an ecologically valid motor sequence learning task through training. However, even multisession posttraining tDCS fails to promote motor learning in progressive MS.
Keyphrases
- multiple sclerosis
- transcranial direct current stimulation
- working memory
- double blind
- white matter
- cross sectional
- virtual reality
- end stage renal disease
- ejection fraction
- newly diagnosed
- clinical trial
- mass spectrometry
- healthcare
- placebo controlled
- social media
- peritoneal dialysis
- randomized controlled trial
- rheumatoid arthritis
- ms ms
- oxidative stress
- health information
- high glucose
- drug induced
- patient reported
- diabetic rats
- patient reported outcomes
- phase iii
- gestational age
- replacement therapy